Financhill
Back

Chart Industries, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
38

GTLS
Chart Industries, Inc.

Last Price:
$206.69
Seasonality Move:
9.25%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.24
Seasonality Move:
-11.9%
Sell
38
Chart Industries, Inc. (GTLS) is a Sell

Is Chart Industries, Inc. a Buy, Sell or Hold?

  • The current Chart Industries, Inc. [GTLS] share price is $206.84. The Score for GTLS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • GTLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GTLS Stock Price Chart

What is Chart Industries, Inc.'s stock price today?

  • The Chart Industries, Inc. share price today is $206.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

GTLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.71 Buy
Relative Strength Index (14 RSI): 80.22 Buy
Chaikin Money Flow: 343622 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (205.2 - 206.32) Buy
Bollinger Bands (100): (198.82 - 204.5) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

GTLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 206.32 Buy
20-day SMA: 205.97 Buy
50-day SMA: 203.89 Buy
200-day SMA: 179.95 Buy
8-day EMA: 206.37 Buy
20-day EMA: 205.82 Buy
50-day EMA: 203.86 Buy
200-day EMA: 188.22 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

Chart Industries, Inc. Earnings Growth & GTLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.68 per share, and an increase next year of $1.42 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

Chart Industries, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):